Oculoplastics, Orbit and Ocular Oncology Services, LV Prasad Eye Institute, Bhubaneswar, 751024, Odisha, India.
Eye (Lond). 2018 Jan;32(1):152-155. doi: 10.1038/eye.2017.154. Epub 2017 Aug 4.
ObjectiveTo report the role of intralesional bleomycin as sole or adjunct therapy in the management of superficial ocular adnexal lymphatic malformations.DesignRetrospective study.ParticipantsThree patients/three eyes.MethodsRetrospective chart analysis of patients receiving intralesional bleomycin sclerotherapy as sole or adjunctive treatment for superficial ocular adnexal lymphatic malformations at a single tertiary level eye care institution.ResultsDegree of clinical regression of the lesions (graded by percentage) and resolution of symptoms and signs associated with the lesions.ConclusionsUse of intralesional bleomycin sclerotherapy appears to be an effective sole or adjunct treatment in the management of superficial ocular adnexal lymphatic malformations.
报告腔内博来霉素作为单一或辅助治疗在浅表眼部附属器淋巴畸形管理中的作用。
回顾性研究。
3 名患者/3 只眼。
对在一家三级眼科医疗机构接受腔内博来霉素硬化治疗作为浅表眼部附属器淋巴畸形的单一或辅助治疗的患者进行回顾性图表分析。
病变的临床消退程度(按百分比分级)和与病变相关的症状和体征的缓解。
腔内博来霉素硬化治疗似乎是治疗浅表眼部附属器淋巴畸形的有效单一或辅助治疗方法。